Search tool

Introduction Prevalence and patterns of drug use is one of the key indicators used by the EMCDDA to assess the drug situation in Europe. It helps with understanding patterns of use, risk perceptions

Introduction On this page you can find all contact information for the EMCDDA as well as instructions for visitors on how to get to our offices from within Lisbon or from Lisbon airport

Introduction On 30 September-1 October 2021, the EMCDDA brings together more than sixty European and international experts for a meeting on the key indicator Drug-related deaths. The meeting provides a space for sharing

Introduction Building on the achievements and results of previous EMCDDA technical cooperation projects, the EMCDDA4GE project will have as overall objective to help enhance national responses to drug-related health and security threats in

Introduction The objectives of the Drug-related infectious diseases (DRID) network are to share latest developments on drug-related infectious diseases in Europe, and to identify steps needed to improve the production, availability and use

Introduction The 2020 annual EMCDDA TDI\Treatment expert meeting took place on the 5th of November 2020 and was adapted to an online format in order to account for the COVID-19 pandemic and respective

Introduction 
 
 Source: EDR 2020
 
  
 
 On 13-14 October 2020, the EMCDDA brings together more than seventy European and international experts for a meeting on the key indicator Drug-related deaths. The meeting provides a

Introduction The meeting organised at the initiative of the EMCDDA aimed at providing an opportunity for mutual exchange about the status-quo and future priorities in the work towards elimination of viral hepatitis among

Introduction The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the European Union. The Lisbon-based agency provides independent scientific evidence and analysis on all aspects

Introduction The task of the Scientific Committee is to assist the Management Board and the Director of the EMCDDA by delivering an opinion on any scientific matter concerning the Centre's activity which the